UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 68

Sortiert nach

Efatutazone, an Oral PPAR-γ Agonist, in Combination With Paclitaxel in Anaplastic Thyroid Cancer: Results of a Multicenter Phase 1 Trial

The journal of clinical endocrinology and metabolism, 2013-06, Vol.98 (6), p.2392-2400

2013

Volltextzugriff (PDF)

The anticancer effects of chaetocin are independent of programmed cell death and hypoxia, and are associated with inhibition of endothelial cell proliferation

British journal of cancer, 2012-01, Vol.106 (2), p.314-323

2012

Volltextzugriff (PDF)

Cytotoxic synergy between flavopiridol (NSC 649890, L86-8275) and various antineoplastic agents : The importance of sequence of administration

Cancer research (Chicago, Ill.), 1997-08, Vol.57 (16), p.3375-3380

1997

Volltextzugriff (PDF)

Flavopiridol : A cytotoxic flavone that induces cell death in noncycling A549 human lung carcinoma cells

Cancer research (Chicago, Ill.), 1996-11, Vol.56 (21), p.4856-4861

1996

Volltextzugriff (PDF)

Flavopiridol binds to duplex DNA

Cancer research (Chicago, Ill.), 2000-05, Vol.60 (9), p.2419-2428

2000

Volltextzugriff (PDF)

Loss of expression of a new member of the DNAJ protein family confers resistance to chemotherapeutic agents used in the treatment of ovarian cancer

Cancer research (Chicago, Ill.), 2001-05, Vol.61 (10), p.4258-4265

2001

Volltextzugriff (PDF)

Effect of P-glycoprotein on flavopiridol sensitivity

British journal of cancer, 2001-05, Vol.84 (10), p.1391-1396

2001

Volltextzugriff (PDF)

The HER tyrosine kinase inhibitor CI1033 enhances cytotoxicity of 7-ethyl-10-hydroxycamptothecin and topotecan by inhibiting breast cancer resistance protein-mediated drug efflux

Cancer research (Chicago, Ill.), 2001-01, Vol.61 (2), p.739-748

2001

Volltextzugriff (PDF)

Characterization of an Ovarian Carcinoma Cell Line Resistant to Cisplatin and Flavopiridol

Clinical cancer research, 2000-02, Vol.6 (2), p.661-670

2000

Volltextzugriff (PDF)

Antitumor Activity of VB-111, a Novel Antiangiogenic Virotherapeutic, in Thyroid Cancer Xenograft Mouse Models

Genes & cancer, 2011-10, Vol.2 (10), p.993-995

2011

Volltextzugriff (PDF)

Cyclosporine A alleviates severe anaemia associated with refractory large granular lymphocytic leukaemia and chronic natural killer cell lymphocytosis

British journal of haematology, 1996-05, Vol.93 (2), p.406-408

1996

Volltextzugriff (PDF)

Acyl Tunichlorins: A New Class of Nickel Chlorins Isolated from the Caribbean Tunicate Trididemnum solidum

Proceedings of the National Academy of Sciences - PNAS, 1996-10, Vol.93 (20), p.10560-10565

1996

Volltextzugriff (PDF)

Anaplastic Thyroid Cancer Patterns of Nodal Disease and Proposed Radiotherapy Target Volumes

International journal of radiation oncology, biology, physics, 2021-11, Vol.111 (3), p.e418-e419

2021

Volltextzugriff (PDF)

Didemnins and Tunichlorin: Novel Natural Products from the Marine Tunicate Trididemnum solidum

Journal of natural products (Washington, D.C.), 1988-01, Vol.51 (1), p.1-21

1988

Volltextzugriff (PDF)

Characterization of caspase processing and activation in HL-60 cell cytosol under cell-free conditions. Nucleotide requirement and inhibitor profile

The Journal of biological chemistry, 1999-08, Vol.274 (32), p.22635-22645

1999

Volltextzugriff (PDF)

A One-Step Method for Protein Estimation in Biological Samples: Nitration of Tyrosine in Nitric Acid

Analytical biochemistry, 1999-02, Vol.267 (1), p.217-221

1999

Volltextzugriff (PDF)

Effect of pazopanib on hair and skin hypopigmentation: A series of three patients

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.e13602-e13602

2010

Volltextzugriff (PDF)

Intensity-modulated radiation therapy combined with concurrent and adjuvant chemotherapy in anaplastic thyroid carcinoma: A single-institution study

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.5591-5591

2010

Volltextzugriff (PDF)

Phase 1 Trial of Flavopiridol Combined with Cisplatin or Carboplatin in Patients with Advanced Malignancies with the Assessment of Pharmacokinetic and Pharmacodynamic End Points

Clinical cancer research, 2005-08, Vol.11 (16), p.5935-5941

2005

Volltextzugriff (PDF)

Flavopiridol disrupts STAT3/DNA interactions, attenuates STAT3-directed transcription, and combines with the Jak kinase inhibitor AG490 to achieve cytotoxic synergy

Molecular cancer therapeutics, 2006-01, Vol.5 (1), p.138-148

2006

Volltextzugriff (PDF)

17-allylaminogeldanamycin in advanced medullary and differentiated thyroid carcinoma

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.5582-5582

2011

Volltextzugriff (PDF)

Phase II trial of pazopanib in progressive, metastatic, iodine-insensitive differentiated thyroid cancers

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.3521-3521

2009

Volltextzugriff (PDF)

Flavopiridol in patients with relapsed or refractory multiple myeloma: a phase 2 trial with clinical and pharmacodynamic end-points

Haematologica (Roma), 2006-03, Vol.91 (3), p.390-393

2006

Volltextzugriff (PDF)

Efficacia del pazopanib nel carcinoma differenziato della tiroide metastatico, progressivo e resistente al radioiodio: risultati di uno studio di fase 2

L'Endocrinologo, 2010-10, Vol.11 (5), p.235-236

2010

Volltextzugriff (PDF)

Gastric ulceration as a complication of hepatic artery infusion chemotherapy

Southern medical journal (Birmingham, Ala.), 1986-06, Vol.79 (6), p.755-757

1986

Volltextzugriff (PDF)

1 – 25 von 68

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(66)
Mit Volltextzugriff
(61)

Publikationsform

Artikel
(68)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Efatutazone, an Oral PPAR-γ Agonist, in Combination With Paclitaxel in Anaplastic Thyroid Cancer: Results of a Multicenter Phase 1 Trial

The anticancer effects of chaetocin are independent of programmed cell death and hypoxia, and are associated with inhibition of endothelial cell proliferation

Cytotoxic synergy between flavopiridol (NSC 649890, L86-8275) and various antineoplastic agents : The importance of sequence of administration

Flavopiridol : A cytotoxic flavone that induces cell death in noncycling A549 human lung carcinoma cells

Flavopiridol binds to duplex DNA

Loss of expression of a new member of the DNAJ protein family confers resistance to chemotherapeutic agents used in the treatment of ovarian cancer

Effect of P-glycoprotein on flavopiridol sensitivity

The HER tyrosine kinase inhibitor CI1033 enhances cytotoxicity of 7-ethyl-10-hydroxycamptothecin and topotecan by inhibiting breast cancer resistance protein-mediated drug efflux

Characterization of an Ovarian Carcinoma Cell Line Resistant to Cisplatin and Flavopiridol

Antitumor Activity of VB-111, a Novel Antiangiogenic Virotherapeutic, in Thyroid Cancer Xenograft Mouse Models

Cyclosporine A alleviates severe anaemia associated with refractory large granular lymphocytic leukaemia and chronic natural killer cell lymphocytosis

Acyl Tunichlorins: A New Class of Nickel Chlorins Isolated from the Caribbean Tunicate Trididemnum solidum

Anaplastic Thyroid Cancer Patterns of Nodal Disease and Proposed Radiotherapy Target Volumes

Didemnins and Tunichlorin: Novel Natural Products from the Marine Tunicate Trididemnum solidum

Characterization of caspase processing and activation in HL-60 cell cytosol under cell-free conditions. Nucleotide requirement and inhibitor profile

A One-Step Method for Protein Estimation in Biological Samples: Nitration of Tyrosine in Nitric Acid

Effect of pazopanib on hair and skin hypopigmentation: A series of three patients

Intensity-modulated radiation therapy combined with concurrent and adjuvant chemotherapy in anaplastic thyroid carcinoma: A single-institution study

Phase 1 Trial of Flavopiridol Combined with Cisplatin or Carboplatin in Patients with Advanced Malignancies with the Assessment of Pharmacokinetic and Pharmacodynamic End Points

Flavopiridol disrupts STAT3/DNA interactions, attenuates STAT3-directed transcription, and combines with the Jak kinase inhibitor AG490 to achieve cytotoxic synergy

17-allylaminogeldanamycin in advanced medullary and differentiated thyroid carcinoma

Phase II trial of pazopanib in progressive, metastatic, iodine-insensitive differentiated thyroid cancers

Flavopiridol in patients with relapsed or refractory multiple myeloma: a phase 2 trial with clinical and pharmacodynamic end-points

Efficacia del pazopanib nel carcinoma differenziato della tiroide metastatico, progressivo e resistente al radioiodio: risultati di uno studio di fase 2

Gastric ulceration as a complication of hepatic artery infusion chemotherapy

Suchergebnisse filtern